CoChat
Sign Up
Cited by 231

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

The Direct Peroxisome Proliferator-activated Receptor Target Fasting-induced Adipose Factor (FIAF/PGAR/ANGPTL4) Is Present in Blood Plasma as a Truncated Protein That Is Increased by Fenofibrate Treatment

Mandard, Stéphane, Zandbergen, Fokko, Tan, Nguan Soon, Escher, Pascal, Patsouris, David, Koenig, Wolfgang, Kleemann, Robert, Bakker, Arjen, Veenman, Frank, Wahli, Walter, Müller, Michael, Kersten, Sander·2004·Journal of Biological Chemistry
DOI 10.1074/jbc.m403058200
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1074/jbc.m403058200

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Figures

Image 1
CC-BY · From the PDF
FIG. 2 FIAF is a probable PPAR 𝛄 target in human adipocytes. Stromal vascular cells were isolated from subcutaneous ( solid line ) and visceral ( dotted line ) adipose tissue from three subjects and put into culture. Cells were differentiated into adipocytes by incubation with adipogenic medium. Expression is expressed relative to glyceraldehyde-3-phosphate dehydrogenase. Human SGBS differentiated adipocytes (day 13) were treated for 40 h with different concentrations of rosiglitazone ( B ) or L165041 ( C ). Concentrations are indicated in 𝛍 M. FIAF gene expression was determined by quantitative RT-PCR.
FIG. 2 FIAF is a probable PPAR 𝛄 target in human adipocytes. Stromal vascular cells were isolated from subcutaneous ( solid line ) and visceral ( dotted line ) adipose tissue from three subjects and put into culture. Cells were differentiated into adipocytes by incubation with adipogenic medium. Expression is expressed relative to glyceraldehyde-3-phosphate dehydrogenase. Human SGBS differentiated adipocytes (day 13) were treated for 40 h with different concentrations of rosiglitazone ( B ) or L165041 ( C ). Concentrations are indicated in 𝛍 M. FIAF gene expression was determined by quantitative RT-PCR.CC-BY · From the PDF
Image 3
CC-BY · From the PDF
Image 4
CC-BY · From the PDF
Image 5
CC-BY · From the PDF
Image 6
CC-BY · From the PDF
FIG. 3 FIAF up-regulation by PPAR 𝛂 is mediated by a PPRE present in intron 3. A , alignment of the PPRE present in intron 3 of the human and mouse FIAF gene with known PPREs. Cons ., consensus. B , binding of the PPAR/RXR heterodimer to putative PPRE as determined by gel shift. A double-stranded response element containing the human ( left ) or mouse ( right ) FIAF PPRE was incubated with in vitro transcribed/translated hPPAR 𝛂 and hRXR 𝛂 , and binding complexes were resolved on a 6% nondenaturing polyacrylamide gel. -Fold excess of specific (malic enzyme PPRE) or nonspecific (ETS oligonucleotide) cold probe is indicated. C , HepG2 cells were transfected with a SEAP reporter vector containing a 350-nucleotide fragment of intron 3 of the human ( left ) or mouse ( right ) FIAF gene and a PPAR expression vector. SEAP activity was determined in the medium 24-48 h post-transfection.
FIG. 3 FIAF up-regulation by PPAR 𝛂 is mediated by a PPRE present in intron 3. A , alignment of the PPRE present in intron 3 of the human and mouse FIAF gene with known PPREs. Cons ., consensus. B , binding of the PPAR/RXR heterodimer to putative PPRE as determined by gel shift. A double-stranded response element containing the human ( left ) or mouse ( right ) FIAF PPRE was incubated with in vitro transcribed/translated hPPAR 𝛂 and hRXR 𝛂 , and binding complexes were resolved on a 6% nondenaturing polyacrylamide gel. -Fold excess of specific (malic enzyme PPRE) or nonspecific (ETS oligonucleotide) cold probe is indicated. C , HepG2 cells were transfected with a SEAP reporter vector containing a 350-nucleotide fragment of intron 3 of the human ( left ) or mouse ( right ) FIAF gene and a PPAR expression vector. SEAP activity was determined in the medium 24-48 h post-transfection.CC-BY · From the PDF
FIG. 4 PPAR 𝛂 and PPAR 𝛄 bind to the PPRE within intron 3 of the FIAF gene in vivo . Chromatin immunoprecipitation of PPRE within intron 3 of the FIAF gene using antibodies against PPAR 𝛂 or PPAR 𝛄 . The gene sequence spanning the putative PPRE and a random control sequence were analyzed by PCR in the immunoprecipitated chromatin of HepG2 cells treated with Wy14643 ( A ), livers of wild-type and PPAR 𝛂 null mice treated or not with WY14643 ( B ), livers of fed or fasted wild-type and PPAR 𝛂 null mice ( C ), or 3T3-L1 preadipocytes and adipocytes ( D ). Preimmune serum was used as a control. PI , preimmune serum; Cntl , random control sequence; Veh , vehicle; WT , wild type; KO , knock-out.
FIG. 4 PPAR 𝛂 and PPAR 𝛄 bind to the PPRE within intron 3 of the FIAF gene in vivo . Chromatin immunoprecipitation of PPRE within intron 3 of the FIAF gene using antibodies against PPAR 𝛂 or PPAR 𝛄 . The gene sequence spanning the putative PPRE and a random control sequence were analyzed by PCR in the immunoprecipitated chromatin of HepG2 cells treated with Wy14643 ( A ), livers of wild-type and PPAR 𝛂 null mice treated or not with WY14643 ( B ), livers of fed or fasted wild-type and PPAR 𝛂 null mice ( C ), or 3T3-L1 preadipocytes and adipocytes ( D ). Preimmune serum was used as a control. PI , preimmune serum; Cntl , random control sequence; Veh , vehicle; WT , wild type; KO , knock-out.CC-BY · From the PDF
Image 9
CC-BY · From the PDF
FIG. 6 The truncated form of FIAF is up-regulated in concert with FIAF mRNA by synthetic RXR/PPAR agonists. mFIAF protein (30 𝛍 g of total protein loaded per lane) and mRNA expression in differentiated 3T3-L1 adipocytes (day 10) after treatment for 48 h with 5 𝛍 M Lg100268 ( A ) or rosiglitazone ( B ) as assessed by Western blot and quantitative RT-PCR are shown. C , mFIAF protein (12 𝛍 g of total protein loaded per lane) and mRNA in liver of mice fed WY14643 (0.1%) for 5 days. D , Western blot of mouse plasma using anti-mFIAF antibody in the absence or presence of the peptide epitope. E , presence of truncated mFIAF variants in mouse white adipose tissue, blood plasma, and mouse liver. The position of native mFIAF is shown by transfection of pcDNA3 expressing mFIAF into HEK293 cells. Medium was collected, precipitated using trichloroacetic acid, and prepared for SDS-PAGE.
FIG. 6 The truncated form of FIAF is up-regulated in concert with FIAF mRNA by synthetic RXR/PPAR agonists. mFIAF protein (30 𝛍 g of total protein loaded per lane) and mRNA expression in differentiated 3T3-L1 adipocytes (day 10) after treatment for 48 h with 5 𝛍 M Lg100268 ( A ) or rosiglitazone ( B ) as assessed by Western blot and quantitative RT-PCR are shown. C , mFIAF protein (12 𝛍 g of total protein loaded per lane) and mRNA in liver of mice fed WY14643 (0.1%) for 5 days. D , Western blot of mouse plasma using anti-mFIAF antibody in the absence or presence of the peptide epitope. E , presence of truncated mFIAF variants in mouse white adipose tissue, blood plasma, and mouse liver. The position of native mFIAF is shown by transfection of pcDNA3 expressing mFIAF into HEK293 cells. Medium was collected, precipitated using trichloroacetic acid, and prepared for SDS-PAGE.CC-BY · From the PDF
Image 11
CC-BY · From the PDF

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 38

  1. Steppan, 2001, Nature, 409, 307, 10.1038/35053000 · DOI · Paper page
  2. Banerjee, 2004, Science, 303, 1195, 10.1126/science.1092341 · DOI
  3. Kim, 2001, J. Biol. Chem., 276, 11252, 10.1074/jbc.C100028200 · DOI
  4. Hu, 1996, J. Biol. Chem., 271, 10697, 10.1074/jbc.271.18.10697 · DOI
  5. Scherer, 1995, J. Biol. Chem., 270, 26746, 10.1074/jbc.270.45.26746 · DOI
  6. Arita, 1999, Biochem. Biophys. Res. Commun., 257, 79, 10.1006/bbrc.1999.0255 · DOI · Paper page
  7. Cianflone, 1989, J. Biol. Chem., 264, 426, 10.1016/S0021-9258(17)31275-9 · DOI
  8. Samad, 1996, J. Clin. Invest., 97, 37, 10.1172/JCI118404 · DOI
  9. Frederich, 1992, Hypertension, 19, 339, 10.1161/01.HYP.19.4.339 · DOI
  10. Trayhurn, 2000, Am. J. Physiol., 279, R2329
  11. Wallenius, 2002, Nat. Med., 8, 75, 10.1038/nm0102-75 · DOI · Paper page
  12. Hotamisligil, 1993, Science, 259, 87, 10.1126/science.7678183 · DOI · Paper page
  13. Kersten, 2000, J. Biol. Chem., 275, 28488, 10.1074/jbc.M004029200 · DOI · Paper page
  14. Kim, 2000, Biochem. J., 346, 603, 10.1042/bj3460603 · DOI
  15. Yoon, 2000, Mol. Cell. Biol., 20, 5343, 10.1128/MCB.20.14.5343-5349.2000 · DOI · Paper page
  16. Belanger, 2002, J. Mol. Cell Cardiol., 34, 765, 10.1006/jmcc.2002.2021 · DOI
  17. Le Jan, 2003, Am. J. Pathol., 162, 1521, 10.1016/S0002-9440(10)64285-X · DOI
  18. Koishi, 2002, Nat. Genet., 30, 151, 10.1038/ng814 · DOI · Paper page
  19. Shimizugawa, 2002, J. Biol. Chem., 277, 33742, 10.1074/jbc.M203215200 · DOI · Paper page
  20. Shimamura, 2003, Biochem. Biophys. Res. Commun., 301, 604, 10.1016/S0006-291X(02)03058-9 · DOI
  21. Yoshida, 2002, J. Lipid Res., 43, 1770, 10.1194/jlr.C200010-JLR200 · DOI · Paper page
  22. Desvergne, 1999, Endocr. Rev., 20, 649
  23. Mandard, 2004, Cell Mol. Life Sci., 61, 393, 10.1007/s00018-003-3216-3 · DOI
  24. Wabitsch, 2001, Int. J. Obes. Relat. Metab. Disord., 25, 8, 10.1038/sj.ijo.0801520 · DOI
  25. Di Poi, 2002, Mol. Cell, 10, 721, 10.1016/S1097-2765(02)00646-9 · DOI
  26. Mars, 2003, Int. J. Obes. Relat. Metab. Disord., 27, 574, 10.1038/sj.ijo.0802266 · DOI
  27. Hukshorn, 2003, Am. J. Clin. Nutr., 77, 771, 10.1093/ajcn/77.4.771 · DOI
  28. Lawrence, 2001, J. Biol. Chem., 276, 31521, 10.1074/jbc.M103306200 · DOI
  29. Hsu, 2001, J. Biol. Chem., 276, 27950, 10.1074/jbc.M100258200 · DOI
  30. Fruebis, 2001, Proc. Natl. Acad. Sci. U. S. A., 98, 2005, 10.1073/pnas.98.4.2005 · DOI
  31. Harris, 1989, Arch. Biochem. Biophys., 275, 315, 10.1016/0003-9861(89)90379-2 · DOI
  32. Steiner, 1998, Curr. Opin. Chem. Biol., 2, 31, 10.1016/S1367-5931(98)80033-1 · DOI
  33. Croissandeau, 2002, J. Cell Sci., 115, 1203, 10.1242/jcs.115.6.1203 · DOI
  34. Banerjee, 2001, J. Biol. Chem., 276, 25970, 10.1074/jbc.M103109200 · DOI
  35. Chen, 2002, J. Endocrinol., 175, 499, 10.1677/joe.0.1750499 · DOI
  36. Ono, 2003, J. Biol. Chem., 278, 41804, 10.1074/jbc.M302861200 · DOI · Paper page
  37. Ge, 2004, J. Biol. Chem., 279, 2038, 10.1074/jbc.M307583200 · DOI · Paper page
  38. Hansmannel, 2003, Biochem. Biophys. Res. Commun., 311, 149, 10.1016/j.bbrc.2003.09.185 · DOI

Cited by

Sorted by citations

Metadata

Authors
Mandard, S., Zandbergen, F., Tan, N. S., Escher, P., Patsouris, D., Koenig, W., Kleemann, R., Bakker, A., Veenman, F., Wahli, W., Müller, M., & Kersten, S.
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
2004-08
Volume
279
Issue
33
Pages
34411-34420
ISSN
0021-9258
DOI
10.1074/jbc.m403058200
Cited by
231
References
2
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review